Essential oils can cause false-positive results of medium-chain acyl-CoA dehydrogenase deficiency

https://doi.org/10.1016/j.ymgmr.2020.100674Get rights and content
Under a Creative Commons license
open access

Abstract

Newborn screening is a public health care program worldwide to prevent patients from critical illness or conditions. Tandem mass spectrometry allows multiplex, inexpensive, and rapid newborn screening. However, mass spectrometry used for newborn screening to date is not able to separate peaks of compounds with similar m/z, which could lead to false-positive results without additional second-tier tests, such as fragmentation. We experienced three neonatal cases with high levels of markers, octanoylcarnitine and octanoylcarnitine/decanoylcarnitine ratio used to pick up possible cases of medium-chain acyl-CoA dehydrogenase (MCAD) deficiency. The babies were born consecutively in a maternity hospital. Their second acylcarnitine profiles were normal, and the genetic tests for ACADM were negative. Analysis of samples extracted from their first Guthrie cards where blood was not stained also showed peaks equivalent to octanoylcarnitine and decanoylcarnitine, indicating contamination. Environmental surveillance in the maternity ward suggested that essential oils used there might contain the contaminated compound. LC-HRMS/MS and in silico analysis revealed that false-positive results might be due to contamination with the essential oils in Guthrie cards, and causal agents were sphinganine (d17:0) and 2-[2-hydroxyethyl(pentadecyl)amino]ethanol. Thus, health care providers should be cautioned about use of essential oils when collecting blood samples on Guthrie cards. False-positive results can waste costly social resources and cause a physical and psychological burden for children and parents.

Keywords

Newborn screening
MCAD deficiency
Octanoylcarnitine
Decanoylcarnitine
Essential oils
False-positive

Abbreviations

NBS
newborn screening
LC-MS/MS
liquid chromatography-tandem mass spectrometry,
MCAD
medium-chain acyl-CoA dehydrogenase,
FAOD
fatty acid oxidation disorder,
C8
octanoylcarnitine,
C10
decanoylcarnitine,
LC-HRMS/MS
liquid chromatography-high resolution-tandem mass spectrometry

Cited by (0)

1

The three authors contributed equally to this work.